The sedative, neurotoxic and embryotoxic effects of (±)-a-phthalimidoglutarimide or thalidomide are now well known. Any of these effects could be due to thalidomide, or to its metabolites, and it is therefore important to identify these metabolites and to study their biological properties. Our studies on thalidomide began with an investigation of the urinary metabolites excreted by rabbits dosed orally with thalidomide and, as will be described in the succeeding paper (Schumacher, Smith & Williams, 1965), it was soon found that a large number of metabolites occurred. In fact, we succeeded in isolating or detecting by colour reactions and paper chromatography all twelve of its possible hydrolysis products.This caused us to suspect that thalidomide might be unstable in solution and in this paper we shall describe the conditions for the spontaneous hydrolysis of thalidomide in aqueous solution at various pH values.In describing the spontaneous hydrolysis and metabolites of thalidomide, it will be useful to refer to Fig. 1, which shows how thalidomide could break down by simple hydrolysis of its substituted amide bonds.
METHODS AND RESULTS
Reference compoundsThese compounds were either obtained as gifts or prepared in this laboratory. A list is given in Table 1 of the sources of reference compounds, their melting points and any other relevant data. The following compounds were synthesized and their properties are described.2-and 4-(o-carboxybenzamido)glutaramic acid and 2-(o-carboxybenzamido)glutaric acid and their sodium salts. (±)-4-Phthalimidoglutaramic acid (5 g) was stirred into an amount of aqueous sodium hydroxide (40% w/v) calculated to yield the disodium salt of (±)-4-(o-carboxybenzamido)glutaramic acid. The greenish solution was allowed to stand at room temperature for 10 min and then methanol (100 ml.) was added. The mixture was kept for 4 to 5 hr. The precipitate which had formed was filtered, washed with methanol and then recrystallized five times from aqueous methanol and dried in a desiccator. The disodium salt of (±)-4-(o-carboxybenzamido)glutaramic acid was obtained as a white crystalline powder in a yield of 80